L

Lilly Ventures

10 employees

Lilly Ventures is an Indiana-based venture capital firm that provides investment to companies in the life sciences sector.

Investor insights

Sectors invested in

Biotechnology45
Health Care27
Therapeutics18
Medical16
Pharmaceutical15
Biopharma10
Life Science5
Biopharmaceuticals4
Chemistry4
Stapled Peptides4
Supportive Care4
Drug Development4
Myelopreservation4
Chemotherapy4
Chemoprotection4
Transient Receptor Potential (TRP) biology3
Information Technology3
PET imaging3
Diabetes3
Dementia3

Funding rounds participated in

$23M sweet spot round size

Most of their 66 investments are in rounds between $12M and $34M

Investor type

Corporate Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Innovation Management
Life Science
Impact Investing
Venture Capital

Date founded

2001

Investments made

I

IpiNovyx Bio raised $10M on October 5, 2021

Investors: Pathway Bioventures, Generation Ventures, Viva BioInnovator and Lilly Ventures

E

Evox Therapeutics Ltd raised $10M on June 9, 2020

Investors: Lilly Ventures

K

Kymera Therapeutics raised $65M on November 13, 2018

Investors: 6 Dimensions Capital, Sanofi Ventures, Bessemer Venture Partners, AJU IB INVESTMENT, Atlas Ventures and Lilly Ventures

S

Sutro Biopharma, Inc. raised $85M on July 26, 2018

Investors: Nexthera Capital, Tekla Capital Management, Samsara BioCapital, Surveyor Capital, Vida Ventures, LLC, Sky Ventures, SV Life Sciences and Lilly Ventures

U

Undisclosed raised $65M on June 5, 2018

Investors: S.R. One Ltd, Atlas Venture, Lightstone Ventures and Lilly Ventures

K

Kymera Therapeutics raised $30M on October 30, 2017

Investors: Atlas Venture and Lilly Ventures

C

Cavion, Inc. raised $26M on January 6, 2017

Investors: Lilly Ventures

S

Symic Biomedical raised $25M on December 1, 2015

Investors: Lilly Ventures

P

Protagonist Therapeutics raised $40M on July 16, 2015

Investors: Adage Capital Management, Canaan, Inbio Ventures, RA Capital Management, L.P., Foresite Capital, Starfish Ventures and Lilly Ventures

A

Aeglea BioTherapeutics raised $44M on March 23, 2015

Investors: Jennison Associates LLC, UT Horizon Fund, OrbiMed Advisors, RA Capital Management, L.P., New Ground Ventures, Venrock and Lilly Ventures

FAQ